Clinical trial
Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected…
NCT00358696 · University of British Columbia, Other · Completed
Key facts
| NCT number | NCT00358696 |
|---|---|
| Title | Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients |
| Official title | TEN Switch - An Observational Phase IV Study to Evaluate the Safety and Efficacy of Substituting Tenofovir for Didanosine in Virologically Controlled HIV-infected Patients Co-infected With Hepatitis C Virus. |
| Lead sponsor | University of British Columbia, Other |
| Collaborators | Health Canada |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV, HIV Infections |
| Intervention type | Drug |
| Interventions | tenofovir |
| Enrollment | 30 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2009 |
| Completion | Oct 1, 2009 |
| First posted | Aug 1, 2006 |
| Last update posted | Oct 20, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: